Search Results 211-220 of 8515 for Apixaban

  1. Heparin and dextrose (intravenous route) - Side effects & uses - Mayo Clinic

    Anagrelide; Anistreplase; Antithrombin, Recombinant; Apixaban; Argatroban; Aspirin; Bemiparin; Betrixaban; Bivalirudin; Bromfenac; Bufexamac; Cangrelor ...

  2. Conivaptan (intravenous route) - Mayo Clinic

    Apalutamide; Apixaban; Aprepitant; Artemether; Asciminib; Astemizole; Atazanavir; Atogepant; Atorvastatin; Avacopan; Avanafil; Avapritinib; Avatrombopag ...

  3. Diclofenac and misoprostol (oral route) - Side effects & dosage - Mayo Clinic

    Apixaban; Ardeparin; Argatroban; Aspirin; Azathioprine; Bemetizide; Bemiparin; Bendroflumethiazide; Benzthiazide; Betrixaban; Bivalirudin; Budesonide ...

  4. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) In Treating Patients With Relapsed Or Refractory Diffuse Large B-Cell Or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...

  5. Minnesota - 2018 Archives - Page 4 of 11 - Mayo Clinic News Network

    SAN DIEGO — Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and[.

  6. Implantable Cardioverter-Defibrillators (Icds) Clinical Trials - Mayo Clinic Research

    The investigators are conducting this study to determine if the anticoagulant medication Apixaban is more effective at reducing MRI detected brain lesions ...

  7. Hematology - Clinical trials

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

  8. A Study To Evaluate The Combination Of Binimetinib And Palbociclib In Treating Patients With KRAS And NRAS Mutant Metastatic Or Unresectable Colorectal Cancer - Mayo Clinic

    The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...

  9. Axatilimab Plus Standard Of Care Therapy For The Prevention Of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Cancer, ABRAXAS Trial - Mayo Clinic

    This phase II trial studies how well adding axatilimab to standard of care (SOC) therapy works in preventing graft versus host disease (GVHD) following ...

  10. Testosterone (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Anisindione; Apixaban ...